LYL273 for Patients With Relapsed or Refractory mCRC
Trial details
- Registry ID
- NCT05319314
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| LYL273 for Patients With Relapsed or Refractory mCRCNCT05319314 | LYEL | Phase 1, Phase 2 | Recruiting | 2028-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |